| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Idexx Laboratories Inc /de (IDXX) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 17 sells. IDXX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 82.4K | $44.55M | - | |
| VP | 13.7K | $7.38M | - | |
| VP | 10.4K | $5.64M | - | |
| VP | 6.3K | $3.42M | - | |
| VP | 1.6K | $866.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2017 | Kingsley Lawrence D60 | Director | Buy | 1,000 | $146.48 | $146,480.00 | +740.7% | |
| Feb 28, 2017 | Henderson Rebecca M | Director | Sell | 6,500 | $145.19 | $943,720.69 | -11.3% | |
| Feb 22, 2017 | Ayers Jonathan W63 | Chairman, President &CEO | Sale+OE | 35,000 | $142.58 | $4,990,134.67 | -1.7% | |
| Feb 16, 2017 | End William T | Director | Sell | 5,000 | $141.71 | $708,534.00 | -9.0% | |
| Feb 8, 2017 | McKeon Brian P69 | Executive VP &CFO | Sale+OE | 9,924 | $141.64 | $1,405,590.62 | -12.2% | |
| Feb 8, 2017 | Ayers Jonathan W63 | Chairman, President &CEO | Sale+OE | 36,250 | $141.63 | $5,134,170.86 | -1.8% | |
| Feb 8, 2017 | Junius Daniel M | Director | Sale+OE | 3,000 | $141.75 | $425,263.50 | -54.6% | |
| Nov 29, 2016 | Ayers Jonathan W63 | Chairman, President &CEO | Sale+OE | 27,424 | $119.77 | $3,284,697.65 | -1.4% | |
| Nov 23, 2016 | Craig Thomas | Director | Sale+OE | 8,500 | $120.06 | $1,020,518.50 | -25.9% | |
| Nov 9, 2016 | Ayers Jonathan W63 | Chairman, President &CEO | Sale+OE | 40,000 | $107.85 | $4,314,187.32 | -1.3% |